Prostate Cancer - Results from #26180

Assessment of daily needle applicator displacement during high-dose-rate interstitial brachytherapy for prostate cancer using daily CT examinations - Abstract May 30, 2012

Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer - Abstract May 30, 2012

Choline PET/CT in the diagnosis of primary and recurrent prostate cancer : Are there evidence-based indications? - Abstract May 30, 2012

A novel curvilinear approach for prostate seed implantation - Abstract May 30, 2012

Treatment outcomes in non-metastatic prostate cancer patients with ultra-high prostate-specific antigen - Abstract May 30, 2012

Antiresorptive treatment options and bone health in cancer patients-safety profiles and clinical considerations - Abstract May 30, 2012

Clinical characterization of prostate cancer potentially insignificant in the prostate biopsy - Abstract May 30, 2012

AUA 2012 - European Randomized Study of Screening for Prostate Cancer (ERSPC): An update after 11 years of follow-up - Slide Presentation May 30, 2012

AUA 2012 - Making sense of all the new options: Pragmatic considerations in CRPC - Slide Presentation May 30, 2012

AUA 2012 - The absence of goal setting in the dialogue between metastatic prostate cancer (mCRPC) patients and their physicians: An opportunity for shared decision making? - Another Perspective May 30, 2012

AUA 2012 - Does long-term aspirin use lower serum PSA levels? – Results from the Duke Prostate Center - Session Highlights May 30, 2012

AUA 2012 - Unilateral prostate cancer: Analysis of predictors in search and Duke Prostate Center databases - Session Highlights May 30, 2012

The dosimetric effect of intrafraction prostate motion on step-and-shoot intensity-modulated radiation therapy plans: Magnitude, correlation with motion parameters, and comparison with helical tomotherapy plans May 30, 2012

AUA 2012 - mCRPC in focus: Androgen biosynthesis inhibition and metastatic castration-resistant prostate cancer, clinical insights from the Clinical Industry Theater presentation by Judd Moul, MD May 30, 2012

Management of patients with metastatic prostate cancer - Abstract May 29, 2012

Genetic ancestry, self-reported race and ethnicity in African Americans and European Americans in the PCaP cohort - Abstract May 29, 2012

Active surveillance for favorable-risk prostate cancer: Background, patient selection, triggers for intervention, and outcomes - Abstract May 29, 2012

EORTC QLQ-BM22 and QLQ-C30 quality of life scores in patients with painful bone metastases of prostate cancer treated with strontium-89 radionuclide therapy - Abstract May 29, 2012

Recent changes in the clinicopathologic features of Korean men with prostate cancer: A comparison with Western populations - Abstract May 29, 2012

Androgen deprivation therapy in prostate cancer. Indication and systemic consequences - Abstract May 29, 2012

Page 1310 of 1458